Amneal Pharmaceuticals (AMRX) PT Raised to $17; Truist: 'Stock pullback a great entry point'
Tweet Send to a Friend
(Updated - March 2, 2026 9:45 AM EST)
Truist Securities analyst Les Sulewski raised the price target on Amneal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Les Sulewski raised the price target on Amneal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
